| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/31/2000 | DE19854357A1 Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Semi-hydrochloride of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.0 / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo -3-quinolinecarboxylic acid |
| 05/31/2000 | DE19854356A1 Kristallmodifikation A von A crystal modification of 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| 05/31/2000 | DE19854355A1 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Crystal modification B of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.O / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo- 3-quinolinecarboxylic acid |
| 05/31/2000 | DE19853476A1 Prolaktin-senkendes Mittel Prolactin-lowering agent |
| 05/31/2000 | DE19853007A1 Irrigation solution for eye surgery, especially cataract surgery, containing hyaluronic acid to protect corneal endothelium |
| 05/31/2000 | CN1255164A Modified antisense nucleotides complementary to section of human Ha-Ras gene |
| 05/31/2000 | CN1255163A Compounds |
| 05/31/2000 | CN1255162A Protease inhibitors |
| 05/31/2000 | CN1255161A Protease inhibitors |
| 05/31/2000 | CN1255142A B-ring estratriene diol sulphates |
| 05/31/2000 | CN1255141A Salts of 5 'alpha'-pregn-16-en-3 'beta'-ol-20-one 3-sulphate ester with progestin activity |
| 05/31/2000 | CN1255136A Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 05/31/2000 | CN1255135A New class of benzoporphyrin derivative photoactive compounds |
| 05/31/2000 | CN1255133A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/31/2000 | CN1255131A Amidine derivatives as inhibitors of nitric oxide synthase |
| 05/31/2000 | CN1255130A Compounds |
| 05/31/2000 | CN1255124A Substituted isoquinoline derivatives and their use as anticonulsants |
| 05/31/2000 | CN1255121A Selective epoxidation process for preparing pharmaceutical compounds |
| 05/31/2000 | CN1255119A Protease inhibitors |
| 05/31/2000 | CN1255117A Excitatory amino acid receptor modulators |
| 05/31/2000 | CN1255066A Plant extracts for the treatment of increase bone resorption |
| 05/31/2000 | CN1255064A Use of 'alpha'-methyl-P-tyrosine to inhibit melanin production in iris melanocytes |
| 05/31/2000 | CN1255063A Photosensitizer conjugates for pathogen targeting |
| 05/31/2000 | CN1255062A Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 05/31/2000 | CN1255061A Use of chelerythrine and radiation for tumor therapy |
| 05/31/2000 | CN1255060A Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 05/31/2000 | CN1255059A COX-2 selective carprofen for treating pain and inflammation in dogs |
| 05/31/2000 | CN1255058A Preventives/remedies for arteriosclerosis |
| 05/31/2000 | CN1255057A Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 05/31/2000 | CN1255056A Intravaginal drug delivery devices for idminsitration of testosterone and testosterone precursors |
| 05/31/2000 | CN1255053A Ascorbyl-phosphoryl-cholesterol |
| 05/31/2000 | CN1255044A Orally active fraction of momordica charactia, active peptides thereof, and their use in the treatment of diabetes |
| 05/31/2000 | CN1255041A Methods and compositions for treatment of aids-associated kaposi's sarcoma |
| 05/31/2000 | CN1254756A Attenuated virus of ox's viral diarrhea |
| 05/31/2000 | CN1254715A Isoesperamicin and its synthesizing process and usage |
| 05/31/2000 | CN1254713A Agarofuran derivatives, their preparing process, medicinal composition containing them and their medicinal usage |
| 05/31/2000 | CN1254597A Antiswelling medicine |
| 05/31/2000 | CN1254596A Process for preparing composition to kill internal parasites |
| 05/31/2000 | CN1254587A Broad-spectrum antibacterial medicine |
| 05/31/2000 | CN1254582A Chinese patent medicine for treating rheumatic hyperosteogeny and its preparing process |
| 05/31/2000 | CN1254579A Exterior-applied liniment for treating hyperosteogeny |
| 05/31/2000 | CN1254562A Process for preparing exterior-applied medicine for treating psoriasis |
| 05/31/2000 | CN1254560A Prednelan composition for treating rheumatism |
| 05/31/2000 | CN1254559A Broad-spectrum antibacterial medicine and its exterior application method |
| 05/31/2000 | CN1254558A S-(3-hydroxypropyl)-L-cysteine composition as oral medicine |
| 05/31/2000 | CN1052984C New erythromycin derivative and its preparing process and application in medicine |
| 05/31/2000 | CN1052979C Carbazolone derivatives and process for preparing same |
| 05/31/2000 | CN1052978C Process for the preparation of alpha-tocopherol |
| 05/31/2000 | CN1052976C Substituted benzenesulfonylureas and -thioureas, preparation process and possible uses of pharmaceutical preparation therefor |
| 05/31/2000 | CN1052910C Granular medicine for curing sterility due to sperm antibody |
| 05/31/2000 | CN1052882C Multipurpose inner coating agent for tooth |
| 05/31/2000 | CN1052878C Buffer choline phosphorus aqueous solution and its preparation method, medicine and usage |
| 05/31/2000 | CN1052877C Ranitidine compositions |
| 05/30/2000 | US6069283 Illudin analogs useful as antitumor agents |
| 05/30/2000 | US6069257 Process for the production of tetrazolylbenzopyrans |
| 05/30/2000 | US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders |
| 05/30/2000 | US6069232 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 05/30/2000 | US6069175 Administering to a mammal in need a therapeutically effective amount of a member selected from the 4-hydroxy tamoxifen, raloxifene, toremifene, centchroman, idoxifene to treat atherosclerosis |
| 05/30/2000 | US6069174 Protein kinase C activators and their use in increasing expression of cell antigens |
| 05/30/2000 | US6069172 Administering the enantiomer (r)-ketoprofen and of its salts with suitable organic and inorganic bases in the therapy of neutrophil-dependent diseases |
| 05/30/2000 | US6069169 Dermatologic and cosmetic use for oxa acids |
| 05/30/2000 | US6069168 Compositions for treatment of diabetic complications |
| 05/30/2000 | US6069165 Administering to the patient suffering from dysthymia, psychoses, paranoid and productive schizophrenias, acute delirous psychoses, an effective amount of amisulpride or salts |
| 05/30/2000 | US6069164 Methods for treating circadian rhythm phase disturbances |
| 05/30/2000 | US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/30/2000 | US6069160 Heteroatom-containing benzocyclopentane-oxazolidinones |
| 05/30/2000 | US6069158 10,11-dihydro-3(3-(4-amino-2-pyridylamino)-1-propyloxy)-5h-dib enzo(a,d)cycloheptene-10-acetic acid |
| 05/30/2000 | US6069156 Indole derivatives as cGMP-PDE inhibitors |
| 05/30/2000 | US6069155 Presurgery anesthetising humans |
| 05/30/2000 | US6069154 In humans; side effect reduction |
| 05/30/2000 | US6069152 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 05/30/2000 | US6069151 Controlling tumor necrosis factor |
| 05/30/2000 | US6069150 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 05/30/2000 | US6069148 Cycloalkano-pyridines |
| 05/30/2000 | US6069147 Adjustment of metabolism |
| 05/30/2000 | US6069146 Halimide, a cytotoxic marine natural product, and derivatives thereof |
| 05/30/2000 | US6069145 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents |
| 05/30/2000 | US6069143 Anticoagulants |
| 05/30/2000 | US6069141 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials |
| 05/30/2000 | US6069140 Pharmaceutical compositions comprising texaphyrins |
| 05/30/2000 | US6069139 Method and composition for prophulaxis and treatment of retinal diseases |
| 05/30/2000 | US6069138 Use of phospholipids of animal origin in therapy and/or dietetics |
| 05/30/2000 | US6069137 Administering oligosaccharide |
| 05/30/2000 | US6069135 Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents |
| 05/30/2000 | US6069134 Methods and compositions comprising DNA damaging agents and p53 |
| 05/30/2000 | US6069133 Targeted delivery of genes encoding interferon |
| 05/30/2000 | US6069131 Fasting 8 hours prior to anesthesia, 2 hours prior to anesthesia ingesting a beverage of carbohydrates whose total calories is about 200, an acid to result in a ph of 3-4.3 and water, fasting; satisfies patient's hunger |
| 05/30/2000 | US6069130 Prodrugs useful in vivo or invitro for preventing or treating coagulation disorders |
| 05/30/2000 | US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences |
| 05/30/2000 | US6068999 Dietary supplement for supporting cerebrovascular tone and treating migraine headaches |
| 05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
| 05/30/2000 | US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype |
| 05/30/2000 | US6068860 For topical administration comprising foscarnet and an antiinflammatory glucocorticoid, with a carrier based on galactolipids comprising digalactosyldiacylglycerols, and a polar solvent; treating herpes infections |
| 05/30/2000 | US6068859 Controlled-release dosage forms of Azithromycin |
| 05/30/2000 | US6068858 Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| 05/30/2000 | US6068856 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| 05/30/2000 | US6068855 Mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixer so as to form an agglomerates, extruding the agglomerate to form an extrudate |
| 05/30/2000 | US6068851 Formulation for use in the prevention of pathogen induced diseases including HIV and HSV |
| 05/30/2000 | US6068846 Hypericum perforatum extract and hydroxytryptophan/5-/ is useful for treating depression and mood disorder |
| 05/30/2000 | US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora |